BLFS 241018 17.50C (BLFS241018C17500) Stock Options, News & Quotes

6.13
+0.03+0.49%

15min DelayClose Oct 18 16:00 ET

6.13High6.13Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

EZ_money

Oct 7 10:09

$Clover Health (CLOV.US)$ buy the dip 😁Hedge funds pile into healthcare stocks amid dip, Goldman Sachs says (NYSEARCA:IYH)" data-render="ssr
$BioLife Solutions (BLFS.US)$ $Emergent BioSolutions (EBS.US)$ $Rockwell Medical (RMTI.US)$

Moomoo AI

Mar 12 08:21

BioLife Solutions, despite more cash than debt, is seen as risky due to lack of profitability and negative cash flow. The company's future financial health hinges on its earnings.

Is BioLife Solutions (NASDAQ:BLFS) Using Too Much Debt?

Moomoo AI

Feb 19 04:28

The stock's low price indicates a potential buying opportunity. However, its high beta suggests volatility. The company's optimistic future outlook isn't fully reflected in the current share price.

Is It Time To Consider Buying BioLife Solutions, Inc. (NASDAQ:BLFS)?

Moomoo AI

Nov 16, 2023 21:39

BioLife Solutions' worrying forecast of increased losses and reduced revenues could wane investor confidence. The company's long-term business trajectory is vital for creating shareholder value.

Downgrade: Here's How Analysts See BioLife Solutions, Inc. (NASDAQ:BLFS) Performing In The Near Term

Moomoo AI

Oct 16, 2023 13:37

Lack of insider transactions might be discouraging for the company's share outlook and the stated insider ownership is not really impressive.

Selling BioLife Solutions Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders